JPMorgan First-Quarter ETF Assets Jump 39% on JEPI, JEPQ Inflows
JPMorgan Chase & Co. (JPM), the sixth-largest ETF issuer, said first-quarter assets in its exchange-traded fund business jumped 39% as inflows surged into its biggest funds, including JEPI and JEPQ.
ETF assets under management rose to $239.9 billion from $172.6 billion in the prior year's first quarter, according to New York-based JPMorgan, the biggest U.S. bank. That growth was fueled in part by the company's ETFs, which pulled in $19.1 billion in flows, a 30% jump from the year-earlier period.
ETF issuers like JPMorgan and BlackRock Inc. (BLK) benefitted as investors plowed $296 billion into ETFs during the first quarter, even as markets dropped, with the S&P 500's 4.6% decline marking its worst first quarter in three years. BlackRock, whose iShares is the world's largest ETF issuer, reported $107 billion in total net inflows into ETFs for the quarter.
JPMorgan is focused on active ETFs, with six of its seven first-quarter launches in that category. Assets in its active business surged 58% to $177.2 billion, and inflows nearly doubled to $18.4 billion. The company doesn't offer the passive, major index-tracking ETFs its rivals rely on to bring in big inflows, instead opting for more specalized, income-generating funds like the $38 billion JPMorgan Equity Premium Income ETF (JEPI). Those funds carry higher management fees than passive funds.
"Q1 has been favorable for active management" in equities and fixed income, Travis Spence, J.P. Morgan Asset Management's global head of ETFs, said in an emailed statement. In equities, the company has "focused on re-evaluating our fundamental views at the company level of post-election changes to earnings momentum, including the recent tariff tantrum, and in fixed income, where both rates and credit spreads are moving."
JEPI, which invests in large-cap stocks and equity-linked notes to generate income, pulled in $2.8 billion in the quarter. JPMorgan's second-largest fund, the $29.9 billion JPMorgan Ultra-Short Income ETF (JPST), pulled in $3.4 billion, while the $22.8 billion JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) took in $4 billion.
Source: etf.com fund flows data
CEO Jamie Dimon struck a cautious tone in the company's earnings release, as the global economy confronts 'considerable turbulence (including geopolitics).' He enumerated economic positives like tax reform and deregulation alongside 'potential negatives of tariffs and 'trade wars,' ongoing sticky inflation, high fiscal deficits and still rather high asset prices and volatility.'
'As always, we hope for the best but prepare the firm for a wide range of scenarios.'Permalink | © Copyright 2025 etf.com. All rights reserved
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Jim Cramer Says America Won't Be 'Truly Liberated' Until It Strikes Rare-Earth Deals With Other Countries: US Doesn't 'Have The Cards'
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Jim Cramer warned that the United States must cut deals with nations other than China for rare-earth minerals, or we'll never be 'truly liberated" from Beijing's grip. What Happened: The CNBC 'Mad Money' host told viewers on Wednesday that China mines about 60% and refines roughly 90% of the world's rare earths. This, as Cramer described earlier this month, gives China "a stranglehold" over supply chains that feed electronics, autos and defense hardware. Trending: Let your money work smarter: . No hidden fees, no commitment. "What the heck were we thinking when we started a trade war without having this rare-earths issue all buttoned up and ready to go?" he asked, adding that Washington doesn't 'have the cards" while it depends on Chinese exports already throttled by new licensing rules. Cramer urged the White House to waive steep tariffs and strike rapid supply pacts with Brazil, Vietnam and Australia, countries he said hold the raw materials for earth minerals and magnets. "We need to make these rare-earth deals with the same alacrity that the White House gave out the reciprocal tariffs on 'liberation day,'" Cramer said. Jim Cramer isn't the only one sounding the alarm bell. Officials have long warned that America's reliance on China for rare-earth minerals creates a strategic threat and in April, China slapped export restrictions on those minerals after President Donald Trump raised tariffs It Matters: According to a Reuters report, Trump said on Wednesday that Beijing would 'supply the minerals up front' as part of a tentative trade framework still awaiting his and President Xi Jinping's signatures. Commerce Secretary Howard Lutnick insists that the accord will ease the curbs, yet analysts note China could tighten shipments again if talks stall. Automakers have already sounded alarms. A Reuters survey found that some European suppliers were idling plants, while others warned of shutdowns by mid-July. An older report reveals companies are willing to "pay any price" for alloys and magnets. Reacting to the development, U.S. Futures were down on Wednesday night, with the S&P 500 futures down 0.30%, trading at 6,011; Nasdaq futures down 0.32%, at 21,818.50; and the Dow Jones futures, trading at 42,764, down 0.34%. Read Next: Level up your portfolio tracking with Snowball Analytics: see all your investments in one dashboard with real-time stock and dividend tracking for free today. Photo courtesy: Shutterstock This article Jim Cramer Says America Won't Be 'Truly Liberated' Until It Strikes Rare-Earth Deals With Other Countries: US Doesn't 'Have The Cards' originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
UK edtech Pearson to raise India headcount by 43% in three years
By Praveen Paramasivam CHENNAI (Reuters) -UK-based Pearson plans to boost its workforce in India by about 43% to 2,000, an executive told Reuters on Friday, months after the education firm named India one of its top three priority markets globally. "We will invest significantly in India. We have got three very strong locations and we want to grow in all of these different locations," said Vishaal Gupta, president of enterprise learning and skills division and chair of India at Pearson. Pearson India operates in education and assessment markets, targeting school goers, students aspiring for colleges overseas and corporate professionals. The company will hire across various functions, including local business operations and global tech, over the next three years, Gupta said, while ruling out the launch of any new office location. It currently has offices in Noida, Bengaluru and Chennai. Pearson's shares hit a 10-year high in February after the company reported a rise in profit and said deploying AI would help deliver more growth in 2025. India's ed-tech market, which was valued at $7.5 billion in 2024, is projected to grow more than three-fold to $29 billion by 2030, according to a Grant Thornton report. In India, Pearson competes with IDP Education and Educational Testing Service in overseas education segment, and with Upgrad and Coursera in the digital-learning market. Gupta said the company will focus on government, Indian conglomerates and global capability centers, where a shortage of skilled workers poses a challenge amid growing demand for AI upskilling. Global capability centers, commonly known as GCCs, are local offices set up by large global companies in India to support their global parent in daily operations, finance, R&D and product development functions. GCCs are projected to contribute 2% to India's GDP by 2030, according to ICICI Securities, up from less than 1% currently. Sign in to access your portfolio
Yahoo
17 minutes ago
- Yahoo
AstraZeneca signs $5 billion research deal with China's CSPC
(Reuters) -AstraZeneca has signed a research agreement worth more than $5 billion with Chinese drugmaker CSPC Pharmaceutical Group, the Anglo-Swedish drugmaker said on Friday. The deal marks the latest effort by AstraZeneca to revive its business in China, where it has faced several challenges including the arrest of its China president last year and potential fines related to imports. Under the agreement, the two companies will collaborate to discover and develop pre-clinical candidates for potential treatments targeting chronic diseases, with CSPC conducting AI-driven research in Shijiazhuang City. Cambridge, UK-based AstraZeneca will pay CSPC an upfront fee of $110 million. The Hong Kong-listed firm is also eligible to receive up to $1.62 billion in development milestones and $3.6 billion in sales-related milestones, AstraZeneca said. In March, AstraZeneca announced plans to invest $2.5 billion in a research and development hub in Beijing, as it works to rebuild trust in its second-largest market.
